Industry Analysis Reports | Health Care | Medical Devices

Wednesday, 14 October 2020

news: Smart insulin pens Market Trends, Analysis, Global demand and forecast

Smart insulin pens are devices used to deliver the accurate dose of insulin to diabetics at the appropriate time. They have gained traction among diabetics due to its simplistic nature and easy to handle mechanism compared to traditional syringes. The global smart insulin pens market report by Market Research Future (MRFR) contains the pertinent drivers and challenges faced by manufacturers during the period of 2018 to 2023.

Smart Insulin Pens Market Overview

The global smart insulin pens market is expected to exhibit 10.4% CAGR during the forecast period (2018-2023) due to high prevalence of diabetes. Furthermore, the use of these devices for the management of diabetes by the general populace in developing countries can bode well for the market during the forecast period. Awareness of advanced drug delivery methods, need for modern treatments, and the alarming cases of diabetes can bolster the global market demand till 2023.

Get Free Sample Copy With Covid19 Impact@https://www.marketresearchfuture.com/sample_request/6789

The surge in the adoption rate of glucose monitoring devices, awareness of these devices, and integration of glucose measurement devices are other drivers of the market. According to the World Health Organization (WHO), diabetes was accountable for 1.2 million deaths in 2012. This can spark the demand for smart insulin pens for proper management of diabetes. Co-pay assistance and medical reimbursement policies covering the purveying of these devices can ensure the continuous sales.

Unfavorable reimbursement policies, risks associated with insulin pens, and increasing costs of insulin pens are challenges faced by the market.

Smart Insulin Pens Market Segmentation

The global smart insulin pens market has been segmented on the basis of product type, usability, and distribution channel.

On the basis of product type, the market has been segmented into first-generation pens and second-generation pens. The second-generation pens segment has been further divided into Bluetooth-enabled and USB connected.

By usability, the segment has been divided into disposable pens and reusable pens. Reusable insulin pens segment is likely to be the fastest growing segment during the forecast period.

The market, by distribution channel, has been segmented into retail pharmacies, diabetes clinics, online medical stores, and hospital pharmacies.

Smart Insulin Pens Market Regional Analysis

The Middle East & Africa (MEA), Americas, Asia Pacific (APAC), and Europe are regions discussed in the global smart insulin pens market report.

The Americas can be the leading region of the global market till 2023 due to favorable policies by regulatory authorities, adoption of advanced technology, and rising prevalence of diabetes among the general populace. The approval of novel injectable devices by regulatory agencies can drive the global smart insulin pens market growth.

The Europe smart insulin pens market is driven by adoption of advanced drug delivery devices, rising cases of diabetics, and presence of major players. According to the World Diabetes Foundation, more than 59 million have been diagnosed with diabetes, with the number purported to touch 71.1 million by 2040.

Government policies for assisting diabetics and rise in disposable income levels of patients are main drivers of the smart insulin pens market in APAC. Large cases of diabetes recorded in Southeast Asia can drive the regional market growth. As per the International Diabetes Federation, the number of diabetics in the region can touch 156 million by 2045.

Competition Outlook

InjexUK, Lilly USA, LLC, Digital Medics Pty Ltd., Companion Medical, Sanofi-Aventis US LLC, Diamesco Co., Ltd., Smith’s Medical, NIPRO Medical Corporation, Novo Nordisk A/S, Biocorp, Emperra GmbH E-Health Technologies, and others are notable players of the global smart insulin pens market. Manufacturers are launching new iterations of smart insulin pens for recording the proper dosage amounts and reminders of taking insulin shots at the appropriate time. For instance, the InPen by Companion Medical can capture mealtime data and shares it on the respective medical mobile application.

Industry News

Recently, Medtronic and Novo Nordisk have decided to pool in their offerings for sharing the data acquired by their smart insulin pens on a common diabetes management platform.

Read More About report@

https://www.marketresearchfuture.com/reports/smart-insulin-pens-market-6789

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Vocal Biomarkers Market to Expand with Significant CAGR During 2018 to 2023

Vocal biomarkers are a novel technique developed to detect the presence of disease from speech characteristics. By decoding the vocal intonations in real-time, the technology can provide holistic treatment and quality patient care. The global vocal biomarkers market report by Market Research Future (MRFR) highlights several developments which can assist diseases combined with supporting drivers and restraints for the period of 2017 and 2023 (forecast period).

Get Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3933

Vocal Biomarkers Market Outlook

The global vocal biomarkers market is bound to touch a valuation of USD 2.5 billion by 2023. It can exhibit a CAGR of 14.3% during the forecast period. It is driven the prevalence of various neurological and psychological diseases such as Huntington’s disease, Alzheimer’s disease, Parkinson’s disease, depression, attention deficit and disruptive behavior disorders, traumatic brain injury, and others. According to the WHO, close to 350 million suffered from depression in 2016 and the Parkinson’s disease Foundation estimated the number of patients affected by the disease to be reaching a number of 10 million in the same year.

Various government organizations are partnering up with private clinics and firms to develop machine learning algorithms for initial detection of diseases. This is exemplified by the alliance of American Heart Association with Mayo Clinic and Beyond Verbal to use voice patterns to detect coronary heart disease at its initial stage. Development of smartphone applications to detect all disease from voice or sounds can provide the global vocal biomarkers the much-needed impetus in the coming years.

You can Also Read Here!! https://www.medgadget.com/2019/06/vocal-biomarkers-market-2019-information-by-type-by-indications-by-end-user-global-size-share-analysis-regional-growth-demand-and-business-opportunities.html

Vocal Biomarkers Market Segmentation Analysis

The global vocal biomarkers market is segmented by type, indication, and end-user.

The global market, by type is segmented into pitch, voice tremor, vocal rise or fall time, phonation time, error rate, amplitude, frequency, and others.

The market, by indication, is segmented into neurological disorders, psychiatric disorders, cardiovascular disorders, respiratory disorders, and others.

Based on end-user, the market is segmented into academic and research, hospitals and clinics, and others.

Vocal Biomarkers Market Regional Analysis

The Middle East & Africa (MEA), Americas, Europe, and Asia Pacific (APAC) are major regions in the global vocal biomarkers market.

The Americas is predicted to dominate the global market due to the U.S. grabbing maximum shares owing to large healthcare expenditure and favorable reimbursement schemes. The fast adoption rate of new technology can be pivotal in driving the vocal biomarkers market. Alternatives to MRI/CT/EEG machines will find demand due to the large elderly populace in the region.

Europe is the second-biggest region for the market due to large awareness levels and expendable income levels of patients. In addition, the need for non-invasive techniques for detection of diseases is ensured to gain traction and pave way for the global vocal biomarkers market.

The APAC region is expected to have the largest potential for the market due to the large patient pool in China and India. On the other hand, the MEA region will contribute to the vocal biomarkers market due to the booming medical sector in Saudi Arabia and UAE.

Vocal Biomarkers Market Competitive Outlook

Audio Profiling, Sonde Health, IBM Corporation, Beyond Verbal, Cogito Corporation, and others are reputed companies currently operating in the global vocal biomarkers market.

Industry Update

Sonde Health has managed to raise close to USD 16 million in series A funding to spur the development of vocal biomarkers. The technology has amassed hundreds of vocal characteristics from recordings to identify changes in pitch, rate of speech, and hoarseness to assess health.

Aural Analytics has published the results of a clinical trial involving the effects of reldesemtiv, a skeletal muscle troponin activator, used in the treatment of spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). The company analyzed vocal biomarkers for the duration of the trial to notice any improvements in speech patterns.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Tuesday, 13 October 2020

Demand On Global Veterinary Pain Management Market Size, Share and Regional Growth by 2027

Global Veterinary Pain Management Market: Information by Product (Medication (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Local Anesthetics, A2-Adrenergic Agonists, Muscle Relaxants, Sedatives), Route of Administration (Oral, Parental, Topical), Devices (Laser Therapy Devices, Electromagnetic Therapy Devices)), Application (Joint Pain (Osteoarthritis, Musculoskeletal Disorders), Postoperative Pain, Cancer, Others) End User (Hospitals & Clinics, Ambulatory Surgery Centers and Others), Distribution Channel (Hospitals and Clinics, Pharmacies, others) - Forecast till 2027

Market Highlights:
Veterinary Pain Management Market is growing rapidly and pervasively mainly due to the spreading awareness towards animal care. People are generally compassionate towards their pets, and they are increasingly becoming aware of animal physiology and psychology and the pain they go through during sickness, injuries, recoveries and after effects of the diseases. Besides, factors such as the increasing number of pet owners and the strengthening bond between owners and their animal companions escalate the market on the global heights.

Get Sample PDF @https://www.marketresearchfuture.com/sample_request/5961

Acknowledging the rapid expansions, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global veterinary pain management market will reach significant growth heights by 2023 registering 8.2% CAGR during the review period (2018 – 2023).

Additional factors substantiating the market growth include the rising per capita income that is leading to increasing the pet adoptions and the trend of nuclear families. Increased awareness concerning animal cruelty is influencing people’s ideologies and knowledge about animals.

Moreover, developments in animal health medicines and vaccines, along with the increased medical treatments are fostering the market growth of veterinary pain management market. Increased R&D expenditure to bring innovations in the products, and development of better and effective veterinary pharmaceuticals and vaccines, etc. are contributing to the market growth.

Improving economic conditions worldwide foster market growth, enabling access to the quality of life, increasing consumers’ buying power, and availing cost-effective veterinary healthcare.

On the other hand, factors such as the lack of awareness and knowledge pertaining to the animal well-being and the rising cost of pet care, etc. are expected to impede the market growth. Also, unavailability of skilled doctors is a major restraint the market is confronting with. Nevertheless, technological advancement, increasing number of ambulatory services coupled with the government and public organizations initiatives like PETA, working towards animal rights and liberation are expected to support market growth.

Veterinary Pain Management Market - Segmentations
MRFR has segmented the analysis into seven key dynamics for better understanding: -

By Drug Type: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Local Anesthetics, Α2-Adrenergic Agonists, Muscle Relaxants, Sedatives, and Corticosteroids among others.

By Devices: Laser Therapy Devices and Electromagnetic Therapy Devices among others.

By Route of Administration: Oral, Parenteral, and Topical among others.

By Animal Type: Companion Animals, Livestock, Research Animals, Aquatic Animals, Zoo Animals, and Exotic Animals among others.

By Application: Joint Pain, Postoperative Pain, and Cancer among others.

By End-user: Veterinary Hospitals & Clinics, Research Institutes & Universities, and Laboratories among others.

By Regions: Europe, North America, APAC and the Rest-of-the-World.

Veterinary Pain Management Market - Geographical Analysis
The North American region accounts for the leading market for veterinary pain management majorly due to the availability of a range of animal care products, emphasis on animal health, and stringent government regulations. Also, technological innovations in the field of veterinary surgical instruments are acting as a tailwind pushing up the market growth in the region.

Additional factors such as growing insurance coverage schemes are expected to push the growth of the veterinary pain management market in the region. Moreover, the increasing number of pets and a large patients’ pool, contribute to the growth of the regional market, demanding various treatment procedures and surgeries.

Countries such as Canada and the US are focusing on exporting surgical equipment and surgical suturing material across the world, which, in turn, is increasing the size of the market in this region. Besides, the growing number of veterinary hospitals fuel market growth.

The Veterinary Pain Management Market in the European region stands the second position in terms of the market size, owing to the increasing pet ownership fuelled by the tax benefits granted by the government. Increase in animal diseases has led to an increasing number of surgeries and veterinary healthcare organizations. European countries like Germany, France, and the U.K, backed by the significant expenditures in the field of manufacturing of veterinary medical and surgical devices, majorly contributes to the growth of the regional market.

The Asia Pacific region is emerging as a promising market for companion veterinary pain management. China among other APAC dominates the regional market whereas, India accounts for the fastest growing market, followed by Australia and Japan. Factors such as the presence of a large patient’s pool, increasing awareness towards animal health, and the improving economy are few of the driving forces pushing up the market in the region.

Veterinary Pain Management Market - Competitive Landscape
The fiercely competitive veterinary pain management market appears to be fragmented due to many players forming a competitive landscape. Mergers & acquisitions, innovations, and Brand reinforcement remain the popular trends for the market players. Acquisitions of local manufactures by multinational companies are changing the market structure, increasing the profit of the company by reducing the competition significantly.

Key Players:
Some of the players leading the market include Zoetis, Boehringer Ingelheim, Chanelle, Ceva Santé Animale, Dechra Pharmaceuticals, Norbrook Laboratories, Merck Animal Health, Elanco, Assisi Animal Health, Bayer, and Vetoquinol.

Industry/ Innovation/ Related News:

November 08, 2018 – Vetoquinol USA, a world-class developer of veterinarian-approved formulas for large animal healthcare products, announced the launch of its rebranded product line - EQUISTRO®. The rebranding includes new packaging for products and others. All EQUISTRO products are now available in veterinary clinics and in retail stores that sell feed, farm supplies, horse tack, and equine products. The rebranding strategy helps to expand the products available for performance horses through Vetoquinol.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/veterinary-pain-management-market-5961

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Spirometry Market -Global Trends, News and Update

The global Spirometry Market is growing rapidly. The market growth attributes to the rising occurrences of respiratory diseases such as asthma and COPD worldwide. Besides, increasing numbers of diagnosis procedures conducted for the detection of interstitial pulmonary fibrosis foster the growth of the market. Moreover, the recent COVID 19 outbreak is projected to escalate the growth of the market exponentially.

Coronavirus has presented considerable challenges to global health services, disturbing almost every aspect of medical practice and policy. Subsequently, there occurs a surge in acute caseload with immediate implications for routine diagnostic and surveillance investigations. These implications have increased numbers of lung function testing (LFT), particularly spirometry, which is performed widely and in a variety of settings. As a result, market revenues are increasing significantly.

According to Market Research Future (MRFR), the valuation of global Spirometry market is expected to reach USD 1,106.76 MN by 2023, growing continually at 10.03% CAGR during the assessment period (2018-2023). Increasing exposure to risk factors among the ever-increasing population is a significant growth driver. Similarly, increasing healthcare expenditures and technological advances in respiratory care devices drive a large share of the market.

In addition to the growing exposure to risk factors such as smoking, pollutants such as chemicals, fumes, and dust, the increasing prevalence of respiratory diseases fosters the growth of the market. Conversely, huge costs associated with tests that require different spirometers and reimbursement limitations are the major factors predicted to obstruct the growth of the market.

Nevertheless, growing government initiatives and funding support to spread awareness and to drive the required R&D to improve diagnostics techniques and devices would support the growth of the market throughout the estimated period.

Global Spirometry Market – Segmentations

The report is segmented into five dynamics;

By Product : Hand-held Spirometry, Table-top Spirometry, Desktop (PC) Spirometry, and others.

By Technology : Volume Measurement Spirometry, Flow Measurement Spirometry (Pneumotachograph System and Mass Flow Meter), Peak Flow Meter (PFM), and others.

By Application : Treatment Monitoring, Diagnostic (Asthma, COPD, Interstitial Pulmonary Fibrosis, others), and others.

By End-user : Research & Academic Institutes, Hospitals & Clinics, Home Care, Diagnostic Centers, and others.

By Regions : Europe, Americas, Asia-Pacific, and Rest-of-the-World.

Spirometry Market – Geographical Analysis

North America dominates the global Spirometry market. The largest market share attributes to the growing prevalence of respiratory diseases such as asthma, COPD, interstitial pulmonary fibrosis, and others. Besides, factors such as the large technological advances and rising adoption of Spirometry devices in the region to improve diagnosis processes drive the growth of the market. Also, the availability of state-of-the-art facilities & infrastructure in the region foster market demand.

Additionally, the growing awareness, alongside the presence of notable industry players, boosts the regional market growth. Furthermore, high healthcare expenditures and expanding rebates on diagnostics push the regional market growth. The North American Spirometry market is projected to reach USD 444.99 MN by 2023, growing at 10.25% CAGR during the forecast period.

Europe stands second in the global spirometry market. The market is largely driven by the presence of major medical device companies in Germany and increasing per capita healthcare expenses in the region. Moreover, factors such as the proliferating healthcare industry and developed infrastructure in the region are driving the market growth further. The Europe spirometry market is expected to create a valuation of USD 322.33 MN by 2023, registering a significant CAGR throughout the review period.

The Spirometry market is brisk in the Asia Pacific region. The region demonstrates enormous growth potential. Additionally, factors such as the availability of cost-competitive diagnostic procedures and devices and large unmet clinical needs for respiratory diseases increase the size of the regional market, providing ample opportunities for market growth. The APAC Spirometry market is assessed to reach USD 247.52 MN by 2023, posting 10.64% CAGR during 2018-2023.

Spirometry Market – Competitive Analysis

The Spirometry market appears highly competitive due to the presence of several well-established players. To gain a larger competitive share, industry players initiate strategies such as mergers & acquisitions, collaboration, expansion, and technology launch. Significant investments are transpired in the field to bring innovations in the therapy and clinical trials. There is a shift towards the hospital testing department, which dominates a large market share. As a result, players rely on their collaborations and partnerships with hospitals to increase market penetration. Besides, these players employ numerous distributions channels and engage insurance companies to retain their market position.

Major Players:

Players active in the global Spirometry market include NDD Medical Technologies, Inc. (US), Nihon Kohden Corporation (Germany), Carefusion Corporation (US), Vitalograph (UK), Schiller AG (Switzerland), MGC Diagnostics Corporation (US), Hill-Rom Holdings, Inc. (US), Midmark Corporation (US), COSMED Srl. (Italy), Smiths Medical Inc. (US), and Koninklijke Philips N.V. (Netherlands), among others.

Industry/ Innovation/ Related News:

June 08, 2020 ---- NHS England announced that thousands of patients with cystic fibrosis (CF), alongside the ones recovering from coronavirus, are being given access to devices and apps to enable remote monitoring of their conditions. CF patients are considered to be at extreme risk from the coronavirus. To enable this group of patients to shield at home as much as possible, patients aged six years, and are given a spirometer to measure their lung capacity, and an app to share this information with their doctor.

NHS England further said that home-based spirometry had been hailed as the most critical intervention by the CF National Network for cystic fibrosis patients. The roll-out of these devices has been accelerated to help patients stay safe at home during the pandemic, while also ensuring the right help fast.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Dental Sterilization Market -trends, Report, Demand, Outlook

Dental Sterilization Market Research Report by Product (Sterilization Equipment, Surface Disinfectant, Instrument Disinfectant, Washer Disinfector, Lubricant, Cleaning Solutions), End-User (Hospitals, Dental Laboratories) - Global Forecast To 2023

Dental sterilization is a highly crucial part of maintaining the tools and techniques related to dentistry. As per the latest published report by Market Research Future (MRFR), the global Dental Sterilization Market is expected to grow at a CAGR of 6.90% during the forecast period of 2017 to 2023. The market valuation is expected to jump from USD 1.11 billion back in 2017 to USD 1.5 billion by the end of the forecast period.

A key driver influencing the demand for dental sterilization is the widespread prevalence of dental related diseases or disorders. Dental caries, one of the most common tooth-related issues, is one of the primary reasons behind the loos of tooth and remains a significant concern across developed economies in the world. Consumption of fast food and sugar-rich food items are acting as the main culprits behind incidences of tooth decay and is likely to continue in the coming years as well, thereby driving the growth of the market over the forecast period.

One of the biggest results out of the growing prevalence of dental diseases have been the rising number of dental care facilities. The growth factor associated with the dentistry field is likely to continue in the near future. This, in turn, helps drive the dental sterilization market towards a period of growth.

Get Latest Sample copy @ https://www.marketresearchfuture.com/sample_request/6659

Market Segmentation

The global dental sterilization market comprises of the following segments: products and end-users.

By product type, the market includes consumables, instruments, and accessories. Among these, the instruments segment is most likely to maintain its dominance over others in terms of market share contribution during the forecast period.

By end-user, the market divides into dental laboratories and hospitals. The hospitals segment is most likely to remain the largest contributor of the two during the forecast period.

Competitive Analysis

The global dental sterilization market comprises of a number of key players, including Matachana Group, Planmeca Group, Danaher, A-Dec, Hu-Friedy, Scican, Tuttnaue, W&H, BMT Medical Technology, Getinge, Midmark, Dentsply Sirona, Nakanishi, Crosstex, and Premier Dental.

March 12^th, 2019, Planmeca became the first-ever dental manufacturer to offer a comprehensive suite of IoT solutions for large clinics as well as clinic chains. The unique device of Planmeca makes it easy to access different sets of data and analyze the same.

March 12^th, 2019, Planmeca and Navigate Surgical Technologies, aka NST, a recognized provider of real-time surgical navigation services, announced their collaboration in order to launch innovative solutions for dental implant surgeries. The partnership is promises to offer dental implant surgeons to deliver enhanced and clinical patient outcomes. The tech offers more precise and accurate implant placement.

Global Dental Sterilization Market by Region

North America
Europe
Asia Pacific
Rest-of-the-World

Regional Analysis

The geographical segmentation of the global dental sterilization market covers the following regions, Europe, Asia Pacific, North America, and the Rest of the World.

North America leads the chart with the highest market share percentage in the global dental sterilization market. This is primarily due to the widespread prevalence of dental-based diseases in the region and ease of availability concerning the use of advanced dental sterilization equipment. Dental caries is one of the most common requirement in dental hygiene, especially in the US, and affects close to 90% of the school-going children. All these factors are poised to make the North American market maintain its topmost standings over the forecast period.

The Asia Pacific region is considered to be an emerging region in the global landscape, however, it plays a major role in the overall development of the market. Herein, fast-paced urbanization in developing countries like India and China has incepted the adoption of Western-like diet system. This has posed to be an increasing problem for the dental health of consumers residing in the Asia Pacific region. Alongside this, the growing number of dental care centers and clinics across these countries is increasingly likely to drive the demand for the global dental sterilization market in the Asia Pacific region during the forecast period.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Latest Research On Global Non-Alcoholic Steatohepatitis Biomarkers Market Size, Technology Trends, Growth Factors, News and forecast

Covid19 Impact on Non-Alcoholic Steatohepatitis (NASH) Biomarkers Global Market 2020- Growth factors, Demand, Current Scenario, Size, Share Investment, Business Opportunities and Challenges

Non-Alcoholic Steatohepatitis (NASH) Biomarkers Global Market Overview

NASH biomarkers are helpful in the identification of liver damage and the severity of the disease. Non-alcoholic steatohepatitis (NASH) is a kind of non-alcoholic fatty liver disease (NAFLD). This disease leads to risks as dangerous as liver failure. Non-alcoholic steatohepatitis biomarkers global market is projected to grow at nearly 21% rate annually. Growth of this market has seen significant growth. It can arise in future due to the absence of tests for NASH treatment, the rapid increase in related patients, demand for non-surgical procedures and increasing awareness. Governments & non-profit groups are spreading the awareness and are investing in research programs, resulting in the spread of NASH biomarkers market.

FREE SAMPLE COPY Available @ https://www.marketresearchfuture.com/sample_request/7984

This disease has affected a large population worldwide, and the efforts to search for diagnose has gained pace in the same period. On seeing this, numerous amounts are being invested in research & development programs by governments and other authorities. Now it has become necessary for companies to keep their eyes and ears open to reach for any advancement, as any cure found can help them in gaining hefty profits and the demands would be high at initial stages.

Apart from all these factors, there are some constraints faced by the industry. At present, the treatment cost of NASH biomarkers is quite high, which makes it far away from sight for economically weaker sections of the society and struggling economies. Also, the rules and regulations established by the authorities are holding back the growth of this industry

Market Segments of Non-Alcoholic Steatohepatitis (NASH) Biomarkers

NASH biomarkers global market has two segments:

Types: Hepatic fibrosis biomarkers, apoptosis biomarkers, oxidative stress biomarkers and other are some types of biomarkers available.

End-Users: Pharma and CRO (contract research organisation) industries, hospitals, diagnostic laboratories and others are some types of biomarker users.

Non-Alcoholic Steatohepatitis (NASH) Biomarkers Global Market Regional Overview

There are four major global NASH markets in America, Europe, Asia Pacific and The Middle East & Africa.

On seeing the market trends, the American region is projected to lead the global market. Factors like the rising occurrence of related diseases, governmental initiatives for awareness & development and already established developed healthcare with increasing demands are responsible for such massive growth in this market. Europe is in second place due to the same features mentioned above.

Asia Pacific market will show moderate growth due to rising population, developments & efforts made for better health infrastructure, the increase in the number of patients and large population. Authorities here are making efforts to fight such conditions and hence increasing the market share and new possibilities.

The Middle East and African region will maintain its slow growth due to struggling healthcare facilities, high implementation costs and limited awareness.

Non-Alcoholic Steatohepatitis (NASH) Biomarkers Global Market Key Players

The prominent players in the global non-alcoholic steatohepatitis biomarkers market are BioPredictive (France), Celerion (US), Cisbio (France), Echosens (France), Enterome (France), GENFIT (France), Laboratory Corporation of America Holdings (US), NGM Biopharmaceuticals (US), One Way Liver, SL (Spain), Pacific Biomarkers (US), Prometheus Laboratories Inc (US), Perspectrum Diagnostics Ltd (UK), Quest Diagnostics, Regulus Therapeutics, Inc. (US), Siemens Healthineers (Germany), Shenzhen New Industries Biomedical Engineering Co., Ltd (China), and Xeptagen SpA (Italy)

Recent Industry News

American region will lead the market with maximum cover during the entire projected period. To gross maximum profit and market share, there is a need to continually work on finding new alternatives with less potential threats as the rules and regulations offered are becoming harsh and narrower with time. Apart from the investments and efforts of the authorities, the industry itself needs to search for better diagnostic measures.

OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/non-alcoholic-steatohepatitis-biomarkers-market-7984

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Medication Management Market Size, Share Analysis, Strategies, Revenue and Forecasts to 2023

Market Insights

Market Research Future predicted that the global Medication Management system Market is set to reach the highest CAGR of 13.4% through the forecast period, 2018-2023.

Medication management focuses on improving medication use for the patient's condition. Interventions may include medication alignment, medication management, patient / family education about medications, and patient medication configuration simulations.

The growing geriatric population is one of the most important factors in the drug management market. Older people often have significant comorbidities that increase drug use and the risk of poor outcomes. According to a 2018 study published in Clinical Epidemiology, polypharmacy affects between 40% and 50% of older people in countries with high-income. Polypharmacy increases the risk of drug-related side effects in older people because more drugs are associated with a higher risk of harmful drug interactions. Several other factors, such as the emergence of funds in the healthcare sector and the need to reduce healthcare costs, are some of the drivers of the market.

However, the high costs of software implementation and service maintenance can hinder the market growth during the forecast period.

Regional Outlook

The United States has dominated the global drug management market. This growth can be ascribed to the rise in the elderly population and the presence of the main market players in the region.

Europe ranked second in 2017 due to the presence of developed economies such as the United Kingdom, Germany, France, and other countries in the region, which is an engine for market growth.

The Asia Pacific region is likely to see the fastest growth in 2017. Factors such as health technology sector growth, increasing market penetration in the region, and growing government support for foreign investment provide regional markets in the region. Asia Pacific.

In addition, the Middle East and Africa had the lowest share of the global drug management market due to the existence of low per capita income and poor economies, especially in the African region. The Middle East region is considered an important market for the Middle East and Africa region.

Market Segmentation

The global Medication management System market is segmented based on systems, services, delivery methods, and end-user.

The global system-based medication management market is divided into computerized physician order entry systems, clinical decision support systems, administration software, inventory management systems, automated dispensing systems, and assurance systems. Administration software segment is further classified as Bar Code Drug Delivery Software (BCMA) and Electronic Drug Management Software (eMAR). The automatic distributor's segment is further classified as centralized automated distribution systems and decentralized automated distribution systems (ADS). A centralized automated dosing system includes robots / dosing systems and automated carousels. The decentralized automated dispensing system (ADS) comprises automated decentralized unit dose metering systems, pharmacy-based decentralized automated dispensing systems, and service-based decentralized automated dispensing systems.

The services market segment is subdivided into point-of-care verification services and drug side effects monitoring.

The global market, on the basis of delivery mode, is divided into on-premise solutions, web-based solutions, and cloud-based solutions.

The market is segmented into pharmacies, hospitals, healthcare facilities, research institutes, and others, based on end-user.

Major Players

The leading players that are supporting the functioning of the global medication management market include General Electric Company, Siemens Ltd, Medical Information Technology, QuadraMed Affinity Corporation, Allscripts Healthcare Solutions, Cerner Corporation, Mckesson Corporation, Omnicell, Inc., Carefusion Corporation, Epic Systems Corporation, and Optum Inc.

Recent Updates

Omnicell, Inc., a leading of medication management solutions for healthcare and pharmacy systems, has announced that Mercy, one of five US healthcare systems for Oklahoma, Arkansas, Missouri, and Kansas, will take over the management of medication in your service network through its Omnicell's automation and intelligence solutions. Omnicell works with major healthcare systems, such as Mercy, and the company launches its vision for independent pharmacies, a step-by-step plan for developing a fully automated zero-error drug management infrastructure. Based on automation, data intelligence, and specialized services, the autonomous pharmacy will allow pharmacists, nurses, physicians, and pharmacist staff to focus on patient and physician satisfaction.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Industry Analysis Reports | Health Care | Medical Devices | Pharmaceutical

Labels

Wednesday, 14 October 2020

news: Smart insulin pens Market Trends, Analysis, Global demand and forecast

Vocal Biomarkers Market to Expand with Significant CAGR During 2018 to 2023

Tuesday, 13 October 2020

Demand On Global Veterinary Pain Management Market Size, Share and Regional Growth by 2027

Spirometry Market -Global Trends, News and Update

Dental Sterilization Market -trends, Report, Demand, Outlook

Latest Research On Global Non-Alcoholic Steatohepatitis Biomarkers Market Size, Technology Trends, Growth Factors, News and forecast

Medication Management Market Size, Share Analysis, Strategies, Revenue and Forecasts to 2023

Blog Archive

Total Pageviews